RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CK Life Sciences Intl (Holdings) - Stock

CK Life Sciences Intl (Holdings) Stocks 2024

CK Life Sciences Intl (Holdings) Stocks

9.61 B

CK Life Sciences Intl (Holdings) Dividend yield

2.19 %

Ticker

775.HK

ISIN

KYG2176J1058

WKN

662762

In 2024, CK Life Sciences Intl (Holdings) had 9.61 B outstanding stocks, a 0% change from the 9.61 B stocks in the previous year.

The CK Life Sciences Intl (Holdings) Stocks history

YEARNUMBER OF STOCKS (undefined HKD)
20239.61
20229.61
20219.61
20209.61
20199.61
20189.61
20179.61
20169.61
20159.61
20149.61
20139.61
20129.61
20119.61
20109.61
20099.61
20089.61
20079.61
20068.76
20057.2
20047.2

CK Life Sciences Intl (Holdings) Aktienanalyse

What does CK Life Sciences Intl (Holdings) do?

CK Life Sciences International (Holdings) Inc (CKLS) is a leading company in the field of life sciences and biotechnology, founded in Hong Kong in 1994. It is a subsidiary of CK Hutchison Holdings, one of the largest conglomerates in Asia. CKLS operates in the business sectors of agricultural sciences, health sciences, and investment. The company has international offices in Australia, the USA, Canada, China, and Europe. The agricultural sciences division of CKLS focuses on research and development of plant-based technologies, including plant breeding, agricultural production, and biological pest control. CKLS specifically engages in the development of breeding techniques that enhance the speed, efficiency, and precision of plant breeding. The goal is to increase agricultural production and reduce the ecological footprint. CKLS also has its own brand of biological plant protection products called ABOUND, which provides protection against pests and diseases. The health sciences division of CKLS encompasses research and development of pharmaceuticals and dietary supplements. The company specializes in the development of dietary supplements made from natural ingredients that are intended to promote health and well-being. An example is the probiotic BioGaia, which is used to support digestive health and treat diarrhea. CKLS also engages in the research of herbal medicine and traditional Chinese medicine. The company has launched its own product line of traditional Chinese medicine, developed based on the millennia-old healing methods of Chinese medicine. The investment division of CKLS focuses on investing in companies and innovations that aim to improve life. For example, CKLS has invested in the US company StemCells, which specializes in the research and development of stem cell transplantation for neurological disorders. Overall, CKLS offers a wide range of products and services aimed at improving people's lives and health. Based on its research and development activities in the biotech industry, the company is working to solidify its leading role in the field of life sciences and biotechnology. In summary, CKLS is a leading company in the field of life sciences and biotechnology, operating in the sectors of agricultural sciences, health sciences, and investment. The company offers a wide range of products and services aimed at improving people's lives and health. CK Life Sciences Intl (Holdings) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating CK Life Sciences Intl (Holdings)'s Shares Outstanding

CK Life Sciences Intl (Holdings)'s shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in CK Life Sciences Intl (Holdings)’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding CK Life Sciences Intl (Holdings)’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in CK Life Sciences Intl (Holdings)’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about CK Life Sciences Intl (Holdings) Stock

How many stocks are there of CK Life Sciences Intl (Holdings)?

The current number of stocks of CK Life Sciences Intl (Holdings) is 9.61 B undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of CK Life Sciences Intl (Holdings) are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of CK Life Sciences Intl (Holdings) evolved in recent years?

The number of shares of CK Life Sciences Intl (Holdings) has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. CK Life Sciences Intl (Holdings) as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of CK Life Sciences Intl (Holdings)?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does CK Life Sciences Intl (Holdings) pay?

Over the past 12 months, CK Life Sciences Intl (Holdings) paid a dividend of 0.01 HKD . This corresponds to a dividend yield of about 2.19 %. For the coming 12 months, CK Life Sciences Intl (Holdings) is expected to pay a dividend of 0.01 HKD.

What is the dividend yield of CK Life Sciences Intl (Holdings)?

The current dividend yield of CK Life Sciences Intl (Holdings) is 2.19 %.

When does CK Life Sciences Intl (Holdings) pay dividends?

CK Life Sciences Intl (Holdings) pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of CK Life Sciences Intl (Holdings)?

CK Life Sciences Intl (Holdings) paid dividends every year for the past 13 years.

What is the dividend of CK Life Sciences Intl (Holdings)?

For the upcoming 12 months, dividends amounting to 0.01 HKD are expected. This corresponds to a dividend yield of 2.19 %.

In which sector is CK Life Sciences Intl (Holdings) located?

CK Life Sciences Intl (Holdings) is assigned to the 'Health' sector.

Wann musste ich die Aktien von CK Life Sciences Intl (Holdings) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CK Life Sciences Intl (Holdings) from 6/5/2023 amounting to 0.008 HKD, you needed to have the stock in your portfolio before the ex-date on 5/23/2023.

When did CK Life Sciences Intl (Holdings) pay the last dividend?

The last dividend was paid out on 6/5/2023.

What was the dividend of CK Life Sciences Intl (Holdings) in the year 2023?

In the year 2023, CK Life Sciences Intl (Holdings) distributed 0.01 HKD as dividends.

In which currency does CK Life Sciences Intl (Holdings) pay out the dividend?

The dividends of CK Life Sciences Intl (Holdings) are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von CK Life Sciences Intl (Holdings)

Our stock analysis for CK Life Sciences Intl (Holdings) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CK Life Sciences Intl (Holdings) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.